SEC Form 4 · accession 0001192482-16-000487
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Theodore R Schroeder
Director
Period of report
Jan 22, 2016
Accepted (ET)
Jan 26, 2016 · 6:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Purchase)F1 | $17.06 | Jan 22, 2016 | A | 15,000 | A | — | Jan 22, 2026 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The option vests and becomes exercisable over a four-year period commencing on January 22, 2016. Twenty-five percent (25%) of the option vests and becomes exercisable on January 22, 2017, and the balance vests in equal monthly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the director's continued service with the issuer.